Annexin presents at Redeye’s Fight Cancer event on January 24
Annexin Pharmaceuticals today announces that the company is participating at Redeye’s theme event Fight Cancer on January 24, 2024. CEO Anders Haegerstrand will present the latest development in the company’s cancer initiative with the drug candidate ANXV.
The presentation and moderated Q&A session will be held in English and is broadcasted live via Redeye’s website https://www.redeye.se/events/966280/redeye-theme-fight-cancer-2?tab=schedule
The presentation will also be available at Annexin’s website afterwards at https://annexinpharma.se/investerare/presentationer/
Time: January 2024 at 15:56 CET
Place: Redeye, Mäster Samuelsgatan 42, Stockholm